These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30562430)

  • 41. Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.
    Yamashita H; Ashida K; Fukuchi T; Nagatani Y; Koga H; Senda K; Eguchi T; Ubukata S; Kawaguchi S; Ueda A; Tanaka T; Ohashi R; Ito D
    J Smooth Muscle Res; 2012; 48(5-6):125-35. PubMed ID: 23538509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
    Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
    Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Longitudinal study of gastroesophageal reflux and erosive tooth wear.
    Wilder-Smith CH; Materna A; Martig L; Lussi A
    BMC Gastroenterol; 2017 Oct; 17(1):113. PubMed ID: 29070010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.
    Nakagawa K; Koike T; Iijima K; Saito M; Kikuchi H; Hatta W; Ara N; Uno K; Asano N; Shimosegawa T
    World J Gastroenterol; 2015 Dec; 21(47):13352-9. PubMed ID: 26715820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reflux profile of Chinese gastroesophageal reflux disease patients with combined multichannel intraluminal impedance-pH monitoring.
    Xiao YL; Lin JK; Cheung TK; Wong NY; Hung IF; Wong BC; Peng S; Wang AJ; Chen MH
    J Gastroenterol Hepatol; 2009 Jun; 24(6):1113-8. PubMed ID: 19638089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Non-erosive reflux disease (NERD)].
    Kasugai K; Funaki Y; Izawa S; Ogasawara N; Sasaki M
    Nihon Rinsho; 2016 Aug; 74(8):1351-1356. PubMed ID: 30562441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
    Yamashita H; Kanamori A; Kano C; Hashimura H; Matsumoto K; Tsujimae M; Yoshizaki T; Momose K; Obata D; Eguchi T; Fujita M; Okada A
    Digestion; 2017; 96(1):52-59. PubMed ID: 28662503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proton pump inhibitors for reflux therapy in infants: effectiveness determined by impedance pH monitoring.
    Castellani C; Huber-Zeyringer A; Bachmaier G; Saxena AK; Höllwarth ME
    Pediatr Surg Int; 2014 Apr; 30(4):381-5. PubMed ID: 24488061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
    Savarino E; Tutuian R; Zentilin P; Dulbecco P; Pohl D; Marabotto E; Parodi A; Sammito G; Gemignani L; Bodini G; Savarino V
    Am J Gastroenterol; 2010 May; 105(5):1053-61. PubMed ID: 19997095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.
    Frazzoni M; de Bortoli N; Frazzoni L; Furnari M; Martinucci I; Tolone S; Farioli A; Marchi S; Fuccio L; Savarino V; Savarino E
    J Gastroenterol; 2017 Apr; 52(4):444-451. PubMed ID: 27241210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signal detection theory approach to gastroesophageal reflux disease: a new method for symptom analysis of impedance-pH data.
    Giral A; Kurt R; Yeğin EG; Yeğin K
    Dis Esophagus; 2014 Apr; 27(3):206-13. PubMed ID: 23795569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The diagnostic impact and limitations of 24 hour pH monitoring with multichannel intraluminal impedance].
    Korszun K; Dyrla P; Wojtuń S; Gil J
    Pol Merkur Lekarski; 2014 Aug; 37(218):73-6. PubMed ID: 25252438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.
    Desjardin M; Luc G; Collet D; Zerbib F
    Neurogastroenterol Motil; 2016 Jan; 28(1):146-52. PubMed ID: 26526815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A study with pharyngeal and esophageal 24-hour pH-impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors.
    Dulery C; Lechot A; Roman S; Bastier PL; Stoll D; de Gabory L; Zerbib F
    Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27424517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients with refractory reflux symptoms often do not have GERD.
    Herregods TV; Troelstra M; Weijenborg PW; Bredenoord AJ; Smout AJ
    Neurogastroenterol Motil; 2015 Sep; 27(9):1267-73. PubMed ID: 26088946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. pH-Impedance Findings and proton pump inhibitors-responsiveness in patients with typical gastroesophageal reflux disease symptoms in a large single-center Italian series.
    Vailati C; Mazzoleni G; Testoni PA; Passaretti S
    J Clin Gastroenterol; 2014 Aug; 48(7):613-9. PubMed ID: 24326754
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Ameliorating Effect of Switching to Vonoprazan: A Novel Potassium-Competitive Acid Blocker in Patients with Proton Pump Inhibitor Refractory Non-Erosive Reflux Disease.
    Abe Y; Koike T; Saito M; Okata T; Nakagawa K; Hatta W; Asanuma K; Uno K; Asano N; Imatani A; Masamune A
    Digestion; 2021; 102(3):480-488. PubMed ID: 32062650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Addition of pH-impedance monitoring to standard pH monitoring increases the yield of symptom association analysis in infants and children with gastroesophageal reflux.
    Loots CM; Benninga MA; Davidson GP; Omari TI
    J Pediatr; 2009 Feb; 154(2):248-52. PubMed ID: 18823910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.